Recursion Pharmaceuticals Stock (NASDAQ: RXRX) stock price, news, charts, stock research, profile.
Open | $9.430 |
Close | - |
Volume / Avg. | 1.052M / 6.377M |
Day Range | 9.250 - 9.615 |
52 Wk Range | 4.970 - 16.745 |
Market Cap | $2.236B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 25.69% |
Days to Cover | 9.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Recursion Pharmaceuticals (NASDAQ: RXRX) through any online brokerage.
Other companies in Recursion Pharmaceuticals’s space includes: MoonLake (NASDAQ:MLTX), PTC Therapeutics (NASDAQ:PTCT), Agios Pharmaceuticals (NASDAQ:AGIO), Dyne Therapeutics (NASDAQ:DYN) and ACADIA Pharmaceuticals (NASDAQ:ACAD).
The latest price target for Recursion Pharmaceuticals (NASDAQ: RXRX) was reported by Needham on Friday, May 10, 2024. The analyst firm set a price target for 17.00 expecting RXRX to rise to within 12 months (a possible 78.76% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $9.51 last updated Today at May 20, 2024 at 11:23 AM EDT.
There are no upcoming dividends for Recursion Pharmaceuticals.
Recursion Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Recursion Pharmaceuticals.
Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.